close
close

Apre-salomemanzo

Breaking: Beyond Headlines!

2024-11-18 | Hims & Hers appoints permanent pharmaceutical, regulatory and quality experts to key leadership positions | NYSE: HIM
aecifo

2024-11-18 | Hims & Hers appoints permanent pharmaceutical, regulatory and quality experts to key leadership positions | NYSE: HIM

Former FDA Deputy Commissioner and former Pfizer & Hillrom Chief Quality Officer join Hims & Hers, strengthening the leadership that drives the company’s high standards of quality and safety.

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced that Deb Autor, former Deputy Commissioner at the FDA, will join the Board of directors’ and Janet Stevens, pharmaceutical quality expert, will join the company as global head of quality and safety. Hims & Hers continues to prioritize security across its entire platform, offerings and leadership so that every customer can have confidence that the solutions they have access to are secure, high quality and personalized for his needs.

This press release contains multimedia. View the full version here:

The former FDA Deputy Commissioner and former Pfizer & Hillrom Chief Quality Officer join Hims & Hers, strengthening the leadership that drives the company's high standards of quality and safety. (Photo: Business Wire)

Former FDA Deputy Commissioner and former Pfizer & Hillrom Chief Quality Officer join Hims & Hers, strengthening the leadership that drives the company’s high standards of quality and safety. (Photo: Business Wire)

Autor brings to Hims & Hers more than 30 years of experience in pharmaceutical quality and compliance, regulatory programs and consumer protection. She previously served as Deputy Commissioner for Global Regulatory Operations and Policy at the FDA, where she oversaw FDA inspections, criminal investigations, and the agency’s international operations. She also served as Director of the Center for Drug Evaluation and Research’s Office of Compliance, leading the enforcement of drug requirements. As a trial lawyer for the Department of Justice, the FDA was his primary client. She also served as Global Head of Regulatory Excellence at AstraZeneca and is currently CEO of Healthcare Innovation Catalysts.

Stevens has spent his entire career in pharmaceutical quality assurance, operations and engineering. She joins Hims & Hers from Hillrom, where she served as Director of Quality, helping the company achieve best-in-class results in global quality regulations. She also served as Pfizer’s Vice President of Sterile Injectables Quality Operations, where she led the company’s quality organizations and enabled successful regulatory inspections globally with regulatory authorities such as the FDA, MHRA and Health Canada.

“We have built a customer experience that prioritizes clinical excellence and the highest standards of safety and quality for every person who trusts us in their journey,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “The deep expertise that Deb and Janet bring to the team is extremely valuable as we continue to evolve our operations to meet the needs of the growing number of customers who come to our platform seeking tailored healthcare solutions to their individual needs.

“There is a lack of affordable, accessible and convenient health care for American consumers, and Hims & Hers fills that need,” said CloseCurlyDoubleQuote; » said Deb Autor. “In my many decades in healthcare, this is the first company I have seen achieve scale, impact and quality while driving innovation to serve patients. It’s an exciting time and I’m thrilled to be a part of it.

“Customers place immense trust in healthcare companies, and Hims & Hers is one of the few companies doing meaningful work to earn that trust,” said CloseCurlyDoubleQuote; » said Janet Stevens. “The security of our operations is the foundation of the bond we maintain with our customers. Continuing to strengthen this connection will be a critical part of impacting more lives on our platform.”

Autor joins healthcare and pharmaceutical industry experts on the Hims & Hers board, including: former Novo Nordisk executive Kåre Schultz; former CEO of the Cleveland Clinic, Dr. Toby Cosgrove; Anja Manuel, US regulatory and foreign policy expert; and former Walgreens Chief Medical Officer and current Hims & Hers Chief Medical Officer Patrick Carroll, among others.

About Him and Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel good through the power of better health. We believe that the way you feel in your body and mind transforms the way you show up in life. This is why we are building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health and wellness challenges and innovates solutions to make it easy to feel happy and healthy. No two people are the same, which is why the company provides access to personalized care designed for results. For more information, please visit www.hims.com And www.forhers.com.